VANTAGE:Consolidation to create the Vanderbilt Technologies for Advanced Genomics

VANTAGE:整合创建范德比尔特先进基因组学技术

基本信息

  • 批准号:
    7935727
  • 负责人:
  • 金额:
    $ 867.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-03-25 至 2013-09-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Recognizing the importance of translating advances in genome science to improved human health, Vanderbilt University School of Medicine has made a commitment to provide state-of-the art laboratory environments and technology through shared resource facilities. To that end, the purpose of this grant application is to optimize an environment conducive to collaboration and acceleration of new biological and clinical discoveries through consolidation of multiple currently physically separate research resources into a centrally located shared resource: VANTAGE (VANderbilt Technologies for Advanced GEnomics). Through complete modernization of an existing 9,316 Net Square Feet of aging, poorly-utilized laboratory space, this proposal will create a physical home for the Genome Technology Core (GTC, a collaborative core for development of next-generation technologies) and BioVU (the Vanderbilt DNA Repository currently housed within the DNA Resources Core), and will enable the consolidation and expansion of four existing core facilities: DNA Resources Core, DNA Sequencing Core, Vanderbilt Microarray Shared Resource (VMSR) and the Flow Cytometry Core. Once renovation is complete, each of these distinct research resources will share collaborative space, thereby creating an institutional nexus of discovery in genomics research by extending and strengthening already successful collaborations. VANTAGE will enable technical synergy, eliminate unnecessary duplication and accelerate discovery in clinical and basic science across the institution. In particular, this renovation will impact over 968 active grants from major Vanderbilt users involving approximately 235 million in annual direct costs.
描述(由申请人提供):认识到将基因组科学的进步转化为改善人类健康的重要性,范德比尔特大学医学院承诺通过共享资源设施提供最先进的实验室环境和技术。为此,该资助申请的目的是通过将多个目前物理上独立的研究资源整合到一个集中的共享资源中来优化有利于合作和加速新的生物学和临床发现的环境:Vantage(范德比尔特Technologies for Advanced GEnomics)。通过对现有的9,316净平方英尺的老化、利用率低的实验室空间进行完全现代化改造,该提案将为基因组技术核心创造一个物理家园。(GTC,下一代技术开发的合作核心)和BioVU(范德比尔特DNA储存库目前位于DNA资源核心内),并将使现有的四个核心设施得到巩固和扩大:DNA资源核心、DNA测序核心、范德比尔特微阵列共享资源(VMSR)和流式细胞术核心。一旦改造完成,这些独特的研究资源中的每一个都将共享合作空间,从而通过扩展和加强已经成功的合作,在基因组学研究中建立一个发现的机构联系。Vantage将实现技术协同作用,消除不必要的重复,并加速整个机构的临床和基础科学发现。特别是,这一改造将影响范德比尔特主要用户提供的968多项积极赠款,涉及每年约2.35亿美元的直接费用。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A guide to single-cell RNA sequencing analysis using web-based tools for non-bioinformatician.
面向非生物信息学家的使用基于网络的工具进行单细胞 RNA 测序分析的指南。
  • DOI:
    10.1111/febs.17036
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yarlagadda,Sagnik;Giorgio,ToddD
  • 通讯作者:
    Giorgio,ToddD
Toxicant-Induced Metabolic Alterations in Lipid and Amino Acid Pathways Are Predictive of Acute Liver Toxicity in Rats.
  • DOI:
    10.3390/ijms21218250
  • 发表时间:
    2020-11-04
  • 期刊:
  • 影响因子:
    5.6
  • 作者:
    Pannala VR;Estes SK;Rahim M;Trenary I;O'Brien TP;Shiota C;Printz RL;Reifman J;Shiota M;Young JD;Wallqvist A
  • 通讯作者:
    Wallqvist A
Assessing Kidney Injury Induced by Mercuric Chloride in Guinea Pigs with In Vivo and In Vitro Experiments.
  • DOI:
    10.3390/ijms24087434
  • 发表时间:
    2023-04-18
  • 期刊:
  • 影响因子:
    5.6
  • 作者:
    Goel, Himanshu;Printz, Richard L.;Shiota, Chiyo;Estes, Shanea K.;Pannala, Venkat;AbdulHameed, Mohamed Diwan M.;Shiota, Masakazu;Wallqvist, Anders
  • 通讯作者:
    Wallqvist, Anders
p52 expression enhances lung cancer progression.
  • DOI:
    10.1038/s41598-018-24488-8
  • 发表时间:
    2018-04-17
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Saxon JA;Yu H;Polosukhin VV;Stathopoulos GT;Gleaves LA;McLoed AG;Massion PP;Yull FE;Zhao Z;Blackwell TS
  • 通讯作者:
    Blackwell TS
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JENNIFER A PIETENPOL其他文献

JENNIFER A PIETENPOL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JENNIFER A PIETENPOL', 18)}}的其他基金

The COVID-19 and Cancer Consortium: NCI Administrative Supplement to P30 Cancer Center Support Grant (CCSG)
COVID-19 和癌症联盟:NCI 对 P30 癌症中心支持补助金 (CCSG) 的行政补充
  • 批准号:
    10332040
  • 财政年份:
    2021
  • 资助金额:
    $ 867.58万
  • 项目类别:
Strategies to Improve Outcomes for triple negative Breast Cancer Patients involv
改善三阴性乳腺癌患者预后的策略包括
  • 批准号:
    8764758
  • 财政年份:
    2014
  • 资助金额:
    $ 867.58万
  • 项目类别:
p63 and p73 Signaling in Cell Growth and Cancer
细胞生长和癌症中的 p63 和 p73 信号转导
  • 批准号:
    8657362
  • 财政年份:
    2013
  • 资助金额:
    $ 867.58万
  • 项目类别:
Supplement
补充
  • 批准号:
    8754463
  • 财政年份:
    2013
  • 资助金额:
    $ 867.58万
  • 项目类别:
Developmental Funds
发展基金
  • 批准号:
    8180539
  • 财政年份:
    2010
  • 资助金额:
    $ 867.58万
  • 项目类别:
Protocol Specific Research Support
协议特定研究支持
  • 批准号:
    8180836
  • 财政年份:
    2010
  • 资助金额:
    $ 867.58万
  • 项目类别:
Senior Leadership
高层领导
  • 批准号:
    8180518
  • 财政年份:
    2010
  • 资助金额:
    $ 867.58万
  • 项目类别:
Program Planning and Evaluation
项目规划与评估
  • 批准号:
    8180535
  • 财政年份:
    2010
  • 资助金额:
    $ 867.58万
  • 项目类别:
P53 Signaling and Cellular Response after Stress
压力后 P53 信号传导和细胞反应
  • 批准号:
    7809840
  • 财政年份:
    2009
  • 资助金额:
    $ 867.58万
  • 项目类别:
Cancer Center Support Grant
癌症中心支持补助金
  • 批准号:
    7931180
  • 财政年份:
    2009
  • 资助金额:
    $ 867.58万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 867.58万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 867.58万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 867.58万
  • 项目类别:
    Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 867.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 867.58万
  • 项目类别:
    Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 867.58万
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 867.58万
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 867.58万
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    $ 867.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    $ 867.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了